The ability of systemic biochemical markers to reflect presence, incidence, and progression of early-stage radiographic knee and hip osteoarthritis: Data from CHECK

Osteoarthritis and Cartilage

Volumn 23, Issue 8, 2015, Pages 1388-1397

  Van Spil, W E ^a   Welsing, P M J ^a   Bierma Zeinstra, S M A ^b   Bijlsma, J W J ^a   Roorda, L D ^c   Cats, H A ^d   Lafeber, F P J G ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Amsterdam Rehabilitation Research Center Reade   (Netherlands)

^d SINT MAARTENSKLINIEK   (Netherlands)

Author keywords

Biomarkers; Hip osteoarthritis; Knee osteoarthritis; Radiography

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; BIOCHEMICAL MARKER; CARBOXY TERMINAL TELOPEPTIDE; CARBOXY TERMINAL TELOPEPTIDE COLLAGEN TYPE 2; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CHONDROITIN SULFATE; CHONDROITIN SULFATE 846; COLLAGEN; HYALURONIC ACID; OSTEOCALCIN; PROCOLLAGEN; PROCOLLAGEN TYPE 1 AMINOPROPEPTIDE; PROCOLLAGEN TYPE 2A AMINOPROPEPTIDE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; PEPTIDE; PEPTIDE FRAGMENT; PROCOLLAGEN TYPE I N-TERMINAL PEPTIDE;

ADULT; ARTICLE; BONE METABOLISM; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HIP OSTEOARTHRITIS; HIP RADIOGRAPHY; HUMAN; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RADIOIMMUNOASSAY; SYNOVIUM; AGED; ARTICULAR CARTILAGE; METABOLISM; MIDDLE AGED; RADIOGRAPHY;

AGED; BIOMARKERS; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CARTILAGE, ARTICULAR; CHONDROITIN SULFATES; COHORT STUDIES; COLLAGEN TYPE I; COLLAGEN TYPE II; DISEASE PROGRESSION; FEMALE; HUMANS; HYALURONIC ACID; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; OSTEOCALCIN; PEPTIDE FRAGMENTS; PEPTIDES; PROCOLLAGEN; SYNOVIAL MEMBRANE;

EID: 84938196140     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2015.03.023     Document Type: Article

References (50)

1. Kraus V.B., Burnett B., Coindreau J., Cottrell S., Eyre D., Gendreau M., et al. Application of biomarkers in the development of drugs intended for the treatment of osteoarthritis. Osteoarthritis Cartilage 2011, 19(5):515-542.
2. van Spil W.E., DeGroot J., Lems W.F., Oostveen J.C., Lafeber F.P. Serum and urinary biochemical markers for knee and hip-osteoarthritis: a systematic review applying the consensus BIPED criteria. Osteoarthritis Cartilage 2010, 18(5):605-612.
3. van Spil W.E., Jansen N.W.D., Bijlsma J.W.J., Reijman M., DeGroot J., Welsing P.M.J., et al. Clusters within a wide spectrum of biochemical markers for osteoarthritis: data from CHECK, a large cohort of individuals with very early symptomatic osteoarthritis. Osteoarthritis Cartilage July 2012, 20(7):745-754.
4. van Spil W.E., Drossaers-Bakker K.W., Lafeber F.P. Associations of CTX-II with biochemical markers of bone turnover raise questions on its tissue origin: data from CHECK, a cohort study of early osteoarthritis. Ann Rheum Dis 2013, 72(1):29-36.
5. Hochberg M.C., Lethbridge-Cejku M., Tobin J.D. Bone mineral density and osteoarthritis: data from the Baltimore Longitudinal Study of Aging. Osteoarthritis Cartilage 2004, 12(Suppl A):S45-S48.
6. Van Spil W.E., Nair S.C., Kinds M.B., Emans P.J., Hilberdink W.K., Welsing P.M., et al. Systemic biochemical markers of joint metabolism and inflammation in relation to radiographic parameters and pain of the knee: data from CHECK, a cohort of early-osteoarthritis subjects. Osteoarthritis Cartilage 2015, 23(1):48-56.
7. Wesseling J., Dekker J., van den Berg W.B., Bierma-Zeinstra S.M., Boers M., Cats H.A., et al. CHECK (Cohort Hip and Cohort Knee): similarities and differences with the Osteoarthritis Initiative. Ann Rheum Dis 2009, 68(9):1413-1419.
8. Kellgren J.H., Lawrence J.S. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957, 16(4):494-502.
9. O'Neill T., Jinks C., Ong B.N. Decision-making regarding total knee replacement surgery: a qualitative meta-synthesis. BMC Health Serv Res 2007, 7:52.
10. Garnero P., Ayral X., Rousseau J.C., Christgau S., Sandell L.J., Dougados M., et al. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 2002, 46(10):2613-2624.
11. Huebner J.L., Kraus V.B. Assessment of the utility of biomarkers of osteoarthritis in the guinea pig. Osteoarthritis Cartilage 2006, 14(9):923-930.
12. Cibere J., Zhang H., Garnero P., Poole A.R., Lobanok T., Saxne T., et al. Association of biomarkers with pre-radiographically defined and radiographically defined knee osteoarthritis in a population-based study. Arthritis Rheum 2009, 60(5):1372-1380.
13. Christensen A.F., Lottenburger T., Lindegaard H., Christgau S., Horslev-Petersen K., Junker P. Differential association of the N-propeptide of collagen IIA (PIIANP) and collagen II C-telopeptide (CTX-II) with synovitis and erosions in early and longstanding rheumatoid arthritis. Clin Exp Rheumatol Mar-Apr 2009, 27(2):307-314.
14. Sharif M., Kirwan J., Charni N., Sandell L.J., Whittles C., Garnero P. A5-yr longitudinal study of type IIA collagen synthesis and total type II collagen degradation in patients with knee osteoarthritis-association with disease progression. Rheumatology (Oxford) Jun 2007, 46(6):938-943.
15. Lippiello L., Hall D., Mankin H.J. Collagen synthesis in normal and osteoarthritic human cartilage. JClin Invest Apr 1977, 59(4):593-600.
16. Catterall J.B., Stabler T.V., Flannery C.R., Kraus V.B. Changes in serum and synovial fluid biomarkers after acute injury (NCT00332254). Arthritis Res Ther 2010, 12(6):R229.
17. Billinghurst R.C., Wu W., Ionescu M., Reiner A., Dahlberg L., Chen J., et al. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Arthritis Rheum Mar 2000, 43(3):664-672.
18. Lohmander L.S., Ionescu M., Jugessur H., Poole A.R. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis. Arthritis Rheum Mar 1999, 42(3):534-544.
19. Matyas J.R., Atley L., Ionescu M., Eyre D.R., Poole A.R. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis. Arthritis Rheum Feb 2004, 50(2):543-552.
20. Wakitani S., Nawata M., Kawaguchi A., Okabe T., Takaoka K., Tsuchiya T., et al. Serum keratan sulfate is a promising marker of early articular cartilage breakdown. Rheumatology (Oxford) Nov 2007, 46(11):1652-1656.
21. Kong S.Y., Stabler T.V., Criscione L.G., Elliott A.L., Jordan J.M., Kraus V.B. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis. Arthritis Rheum 2006, 54(8):2496-2504.
22. Hunter D.J., Li J., LaValley M., Bauer D.C., Nevitt M., DeGroot J., et al. Cartilage markers and their association with cartilage loss on magnetic resonance imaging in knee osteoarthritis: the Boston Osteoarthritis Knee Study. Arthritis Res Ther 2007, 9(5):R108.
23. Mazzuca S.A., Poole A.R., Brandt K.D., Katz B.P., Lane K.A., Lobanok T. Associations between joint space narrowing and molecular markers of collagen and proteoglycan turnover in patients with knee osteoarthritis. JRheumatol Jun 2006, 33(6):1147-1151.
24. Kumm J., Tamm A., Lintrop M., Tamm A. Association between ultrasonographic findings and bone/cartilage biomarkers in patients with early-stage knee osteoarthritis. Calcif Tissue Int Dec 2009, 85(6):514-522.
25. Benito M.J., Veale D.J., FitzGerald O., van den Berg W.B., Bresnihan B. Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis Sep 2005, 64(9):1263-1267.
26. Sharif M., George E., Shepstone L., Knudson W., Thonar E.J., Cushnaghan J., et al. Serum hyaluronic acid level as a predictor of disease progression in osteoarthritis of the knee. Arthritis Rheum Jun 1995, 38(6):760-767.
27. Spector T.D., Hart D.J., Nandra D., Doyle D.V., Mackillop N., Gallimore J.R., et al. Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum Apr 1997, 40(4):723-727.
28. Krasnokutsky S., Belitskaya-Levy I., Bencardino J., Samuels J., Attur M., Regatte R., et al. Quantitative magnetic resonance imaging evidence of synovial proliferation is associated with radiographic severity of knee osteoarthritis. Arthritis Rheum Oct 2011, 63(10):2983-2991.
29. Garnero P., Mazieres B., Gueguen A., Abbal M., Berdah L., Lequesne M., et al. Cross-sectional association of 10 molecular markers of bone, cartilage, and synovium with disease activity and radiological joint damage in patients with hip osteoarthritis: the ECHODIAH cohort. JRheumatol Apr 2005, 32(4):697-703.
30. Mazieres B., Garnero P., Gueguen A., Abbal M., Berdah L., Lequesne M., et al. Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort. Ann Rheum Dis Mar 2006, 65(3):354-359.
31. Nagy Z., Czirjak L. Increased levels of amino terminal propeptide of type III procollagen are an unfavourable predictor of survival in systemic sclerosis. Clin Exp Rheumatol Mar-Apr 2005, 23(2):165-172.
32. Suk K.T., Kim D.J., Kim C.H., Park S.H., Cheong J.Y., Cho S.W., et al. Diagnostic accuracy of biomarkers measured in the hepatic vein and peripheral vein in the prediction of advanced fibrosis in patients with chronic viral hepatitis. Clin Biochem 2012, 45. [Epub 2012 May 8].
33. Garnero P., Piperno M., Gineyts E., Christgau S., Delmas P.D., Vignon E. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage. Ann Rheum Dis Jun 2001, 60(6):619-626.
34. Garnero P., Gineyts E., Christgau S., Finck B., Delmas P.D. Association of baseline levels of urinary glucosyl-galactosyl-pyridinoline and type II collagen C-telopeptide with progression of joint destruction in patients with early rheumatoid arthritis. Arthritis Rheum Jan 2002, 46(1):21-30.
35. Manicourt D.H., Altman R.D., Williams J.M., Devogelaer J.P., Druetz-Van Egeren A., Lenz M.E., et al. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions. Arthritis Rheum Jun 1999, 42(6):1159-1167.
36. Hayami T., Pickarski M., Wesolowski G.A., McLane J., Bone A., Destefano J., et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum Apr 2004, 50(4):1193-1206.
37. Buckland-Wright J.C., Messent E.A., Bingham C.O., Ward R.J., Tonkin C. A2 yr longitudinal radiographic study examining the effect of a bisphosphonate (risedronate) upon subchondral bone loss in osteoarthritic knee patients. Rheumatology (Oxford) 2007, Feb 46(2):257-264.
38. Cooper C., Reginster J.Y., Chapurlat R., Christiansen C., Genant H., Bellamy N., et al. Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial. Curr Med Res Opin Feb 2012, 28(2):231-239.
39. Bettica P., Cline G., Hart D.J., Meyer J., Spector T.D. Evidence for increased bone resorption in patients with progressive knee osteoarthritis: longitudinal results from the Chingford study. Arthritis Rheum Dec 2002, 46(12):3178-3184.
40. Gevers G., Dequeker J. Collagen and non-collagenous protein content (osteocalcin, sialoprotein, proteoglycan) in the iliac crest bone and serum osteocalcin in women with and without hand osteoarthritis. Coll Relat Res Dec 1987, 7(6):435-442.
41. Sowers M., Lachance L., Jamadar D., Hochberg M.C., Hollis B., Crutchfield M., et al. The associations of bone mineral density and bone turnover markers with osteoarthritis of the hand and knee in pre- and perimenopausal women. Arthritis Rheum Mar 1999, 42(3):483-489.
42. Chaganti R.K., Kelman A., Lui L., Yao W., Javaid M.K., Bauer D., et al. Change in serum measurements of cartilage oligomeric matrix protein and association with the development and worsening of radiographic hip osteoarthritis. Osteoarthritis Cartilage May 2008, 16(5):566-571.
43. Berger C.E., Kroner A., Stiegler H., Leitha T., Engel A. Elevated levels of serum type I collagen C-telopeptide in patients with rapidly destructive osteoarthritis of the hip. Int Orthop Feb 2005, 29(1):1-5.
44. Garnero P., Conrozier T., Christgau S., Mathieu P., Delmas P.D., Vignon E. Urinary type II collagen C-telopeptide levels are increased in patients with rapidly destructive hip osteoarthritis. Ann Rheum Dis Oct 2003, 62(10):939-943.
45. Reijman M., Pols H.A., Bergink A.P., Hazes J.M., Belo J.N., Lievense A.M., et al. Body mass index associated with onset and progression of osteoarthritis of the knee but not of the hip: the Rotterdam Study. Ann Rheum Dis Feb 2007, 66(2):158-162.
46. Hart D.J., Spector T.D. Kellgren & Lawrence grade 1 osteophytes in the knee-doubtful or definite?. Osteoarthritis Cartilage Feb 2003, 11(2):149-150.
47. Zhang Y., Hannan M.T., Chaisson C.E., McAlindon T.E., Evans S.R., Aliabadi P., et al. Bone mineral density and risk of incident and progressive radiographic knee osteoarthritis in women: the Framingham Study. JRheumatol Apr 2000, 27(4):1032-1037.
48. Thorp L.E., Wimmer M.A., Block J.A., Moisio K.C., Shott S., Goker B., et al. Bone mineral density in the proximal tibia varies as a function of static alignment and knee adduction angular momentum in individuals with medial knee osteoarthritis. Bone Nov 2006, 39(5):1116-1122.
49. Shakoor N., Dua A., Thorp L.E., Mikolaitis R.A., Wimmer M.A., Foucher K.C., et al. Asymmetric loading and bone mineral density at the asymptomatic knees of patients with unilateral hip osteoarthritis. Arthritis Rheum Dec 2011, 63(12):3853-3858.
50. Sharif M., Kirwan J.R., Elson C.J., Granell R., Clarke S. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years. Arthritis Rheum Aug 2004, 50(8):2479-2488.